
Polypill/Aspirin Combination Reduces Cardiovascular Events in Participants with Increased CV Risk
How to Cite
OrthoEvidence. Polypill/Aspirin Combination Reduces Cardiovascular Events in Participants with Increased CV Risk. ACE Report. 2020;9(11):34. Available from: https://myorthoevidene.com/AceReport/Report/12645
Polypill with or without Aspirin in Persons without Cardiovascular Disease
N Engl J Med. 2020 Nov 13.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Five thousand, seven hundred and thirteen patients with elevated cardiovascular risk were randomized to receive a polypill (containing lipid and blood pressuring lowering agents), aspirin, polypill and aspirin, or placebo for the prevention of cardiovascular events. The primary outcome of interest for the polypill and polypill plus aspirin groups was a composite of death from major cardiovascular ...
To view the full report, start your 30-day free trial today
No credit card required
JOIN LOGIN Forgot Password?Not sure if you want to join OrthoEvidence?
Access this report without an Account.Success, an email containing a link to access this report has been sent to your inbox.
Explore some of our unlocked reports below!

Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.
LEARN MORE
Please Login or Join to leave comments.